评 Subhadra 等人的研究：Bi121 对 SARS-CoV-2 不同变体具有显著的广谱抗病毒活性。2023 年，……，1299.
Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. 2023, , 1299.
机构信息
Preclinical Research and Development, Willmar Schwabe GmbH & Co. KG, Willmar-Schwabe-Straße 4, D-76227 Karlsruhe, Germany.
出版信息
Viruses. 2023 Nov 17;15(11):2268. doi: 10.3390/v15112268.
Abstract
The article "Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2" by Subhadra et al. [...].
摘要
文章“Bi121 对 SARS-CoV-2 不同变体的显著广谱抗病毒活性”，作者 Subhadra 等。[……]
相似文献
1
Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. 2023, , 1299.
Viruses. 2023 Nov 17;15(11):2268. doi: 10.3390/v15112268.
2
Reply to Kulić, Ž. Comment on "Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. 2023, , 1299".
Viruses. 2023 Nov 17;15(11):2269. doi: 10.3390/v15112269.
3
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
Viruses. 2023 May 31;15(6):1299. doi: 10.3390/v15061299.
4
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Antiviral Res. 2023 Sep;217:105677. doi: 10.1016/j.antiviral.2023.105677. Epub 2023 Jul 20.
5
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
6
Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0095323. doi: 10.1128/aac.00953-23. Epub 2023 Dec 4.
7
Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N-hydroxycytidine (NHC) and a 3'-fluoro-substituted analogue of NHC.
Bioorg Chem. 2023 Jun;135:106527. doi: 10.1016/j.bioorg.2023.106527. Epub 2023 Apr 6.
8
In vitro and in vivo effects of 3-indoleacetonitrile-A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection.
Antiviral Res. 2023 Jan;209:105465. doi: 10.1016/j.antiviral.2022.105465. Epub 2022 Nov 17.
9
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern.
Front Cell Infect Microbiol. 2022 Aug 30;12:989534. doi: 10.3389/fcimb.2022.989534. eCollection 2022.
10
Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0049121. doi: 10.1128/AAC.00491-21.
引用本文的文献
1
Reply to Kulić, Ž. Comment on "Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. 2023, , 1299".
Viruses. 2023 Nov 17;15(11):2269. doi: 10.3390/v15112269.
本文引用的文献
1
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
Viruses. 2023 May 31;15(6):1299. doi: 10.3390/v15061299.
2
Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines.
Front Pharmacol. 2022 Sep 13;13:953205. doi: 10.3389/fphar.2022.953205. eCollection 2022.
3
Up-Regulated Vitamin D Receptor by Extract EPs 7630 Contributes to Rhinovirus Defense in Bronchial Epithelial Cells.
Pharmaceuticals (Basel). 2021 Feb 22;14(2):172. doi: 10.3390/ph14020172.
4
The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor.
PLoS One. 2014 Jan 29;9(1):e87487. doi: 10.1371/journal.pone.0087487. eCollection 2014.
Zotero 插件